Metraipolis › archive › dc_f251588037bc

Hepatic safety of pretomanid- and pyrazinamide-containing regimens in TB Alliance clinical trials — Europe PMC PMID:40821686

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40821686
DOI
10.5588/ijtldopen.25.0199
License (as archived)
solo-consultazione
Archived
2026-11-10T16:40:10.443Z
SHA-256 of the archived text
1021b96c616c59ca5ca7314de765aeeb43ce0febd619681ee12164adcbaae731
Stable URL of this page
https://metraipolis.com/documento/dc_f251588037bc

How to cite

Hepatic safety of pretomanid- and pyrazinamide-containing regimens in TB Alliance clinical trials — Europe PMC PMID:40821686 — Europe PMC (en), https://europepmc.org/article/MED/40821686 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f251588037bc (Metraipolis archive dc_f251588037bc, sha256 1021b96c616c59ca5ca7314de765aeeb43ce0febd619681ee12164adcbaae731)
BibTeX
@misc{dcf251588037bc,
  title = {Hepatic safety of pretomanid- and pyrazinamide-containing regimens in TB Alliance clinical trials — Europe PMC PMID:40821686},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40821686},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f251588037bc; sha256 1021b96c616c59ca5ca7314de765aeeb43ce0febd619681ee12164adcbaae731},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40821686. Agents can read the archived copy with the MCP tool read_document.